William Blair Reaffirms Their Buy Rating on Novanta (NOVT)
In a report released today, Brian Drab from William Blair maintained a Buy rating on Novanta (NOVT – Research Report). The company’s shares ...
William Blair Remains a Buy on Baldwin Insurance Group (BWIN)
William Blair analyst Adam Klauber maintained a Buy rating on Baldwin Insurance Group (BWIN – Research Report) today. The company’s shares ...
Nektar Therapeutics’ (NKTR) “Market Perform” Rating Reaffirmed at William Blair
William Blair reiterated their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report issued on Tuesday,RTT News reports. Other research analysts have also ...
Workday Stock Soars as Forecasts Ease ‘Wall of Worry’ Over Outlook
Shares of Workday were rising sharply after the software company turned in quarterly results and financial guidance that ...
PayPal has some big new growth targets. Can it hit its marks?
At Tuesday's event, PayPal rolled out its fiscal 2027 targets, including for 8% to 10% growth in branded checkout volume. That's up from the 6% growth seen in the latest quarter. On the whole as a ...
Allspring Global Investments Holdings LLC Grows Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Allspring Global Investments Holdings LLC raised its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The institutional ...
Letters to the Gazette
Letters to the editor for Feb. 26.
Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsRyan Peterson – Investor RelationsKevin Smith ...